CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing small molecule mimetics of neurotrophins to treat neurodegenerative diseases. By improving pharmacokinetic properties, these mimetics aim to enhance neuroprotection and promote neurogenesis, paving the way for new therapies in this critical health domain.
Neurodegenerative diseases (ND) like AD, PD, MS and ALS/MND are on the rise in developed societies worldwide.
Currently, there exists no cure for any ND, and most of the available drugs fail to tackle ND pathogenesis.
Preclinical studies point to the therapeutic potential of neurotrophins, which have been shown to control a number of aspects of survival, development and function of neurons.
However, the poor pharmacokinetic properties of neurotrophins render their use as drugs prohibitive.The k…
NATIONAL HELLENIC RESEARCH FOUNDATION EIE NHRF
ETHNIKO IDRYMA EREVNON
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Siena
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Caen Cedex 5
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Greece, Athina
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
